-
Mashup Score: 1Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Disseminated blastic plasmacytoid dendritic cell neoplasm - 1 year(s) ago
Sanam Loghavi, Joseph D. Khoury; Disseminated blastic plasmacytoid dendritic cell neoplasm, Blood, Volume 126, Issue 4, 23 July 2015, Pages 558, https://doi.org
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) are reported in up to 20% patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), where a shared clonal origin is shown in individual case studies. In this study, we performed targeted next generating sequencing on multiple bone marrow (BM), skin or sorted cells from 51 BPDCN patients (68.7 years,14.4–84.7), and…
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy - PubMed - 1 year(s) ago
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy arising from the aberrant transformation of plasmacytoid dendritic cells (pDCs) and involving skin, bone marrow, lymph nodes, and central nervous system. Characteristically unique from other myeloid neoplasms, BPDC …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Defining PIK3R5-related PI3K gamma dependency as a novel therapeutic target in blood cancers including BPDCN | Leukemia and Lymphoma Society - 1 year(s) ago
Qingyu Luo MD PhD Dana-Farber Cancer Institute Project Term: July 1, 2022 – June 30, 2025 Project SummaryBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive blood cancer without adequate…
Source: www.lls.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4
For personalized disease and treatment information, or to learn about clinical trials, contact one of The Leukemia & Lymphoma Society’s (LLS’s) Information Specialists at (800) 955-4572. Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) was previously known as natural killer (NK) cell leukemia/lymphoma. As understanding of the…
Source: www.lls.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), previously known as natural killer (NK) cell leukemia/lymphoma, is very often misdiagnosed and under-reported.
Source: www.lls.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
At age 16, Caitlin faced her diagnosis of Blastic plasmacytoid dendritic cell neoplasm (BPDCN) with positivity & support from LLS. Today on #BPDCNDay, we're bringing awareness to this often misdiagnosed & under-reported form of blood cancer. Learn more >> https://t.co/69a3XvAjTd https://t.co/42ah3C6Eh0
-
-
Mashup Score: 0
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), previously known as natural killer (NK) cell leukemia/lymphoma, is very often misdiagnosed and under-reported.
Source: www.lls.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Tomorrow is #BPDCNDay, and we're bringing awareness to blastic plasmacytoid dendritic cell neoplasm (BPDCN). Learn more about what #BPDCN is, facts and statistics about the disease, and our resources for patients dealing with this diagnosis >> https://t.co/hTwW5AL8GU @BPDCNInfo https://t.co/00jR2u1TRH
-
-
Mashup Score: 20Disseminated blastic plasmacytoid dendritic cell neoplasm | Blood | American Society of Hematology - 4 year(s) ago
Sanam Loghavi, Joseph D. Khoury; Disseminated blastic plasmacytoid dendritic cell neoplasm, Blood, Volume 126, Issue 4, 23 July 2015, Pages 558, https://doi.or
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
Today is #BPDCNDay! We are throwing back to a recent interview with @doctorpemm on how a CD123-targeted therapy shows long-term benefit for #BPDCN patients: https://t.co/V8epdw7UVM https://t.co/wwuh4udZPm